The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia

Journal of Immunology

Volumn 181, Issue 11, 2009, Pages 7958-7968

  Olson, Matthew R ^a   Hartwig, Stacey M ^a   Varga, Steven M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GUANINE NUCLEOTIDE BINDING PROTEIN; HYBRID PROTEIN; MACROPHAGE DERIVED CHEMOKINE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BAGG ALBINO MOUSE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNIZATION; LOEFFLER PNEUMONIA; LUNG; LYMPHOCYTE COUNT; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TH2 CELL; VIRUS INFECTION; VIRUS RECOMBINANT;

EID: 71849118589     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.11.7958     Document Type: Article

References (44)

1. Heilman, C. A. 1990. National Institute of Allergy and Infectious Diseases and the World Health Organization: respiratory syncytial and parainfluenza viruses. J. Infect. Dis. 161: 402-406.
2. Falsey, A. R., P. A. Hennessey, M. A. Formica, C. Cox, and E. E. Walsh. 2005. Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 352: 1749-1759. (Pubitemid 40570923)
3. Falsey, A. R., and E. E. Walsh. 2005. Respiratory syncytial virus infection in elderly adults. Drugs Aging 22: 577-587. (Pubitemid 41214551)
4. Fulginiti, V. A., J. J. Eller, O. F. Sieber, J. W. Joyner, M. Minamitani, and G. Meiklejohn. 1969. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am. J. Epidemiol. 89: 435-448.
5. Kapikian, A. Z., R. H. Mitchell, R. M. Chanock, R. A. Shvedoff, and C. E. Stewart. 1969. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89: 405-421.
6. Kim, H. W., J. G. Canchola, C. D. Brandt, G. Pyles, R. M. Chanock, K. Jensen, and R. H. Parrott. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89: 422-434.
7. Olson, M. R., and S. M. Varga. 2007. CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease. J. Immunol. 179: 5415-5424.
8. + T cell responses. J. Immunol. 165: 6487-6495.
9. Johnson, T. R., J. E. Johnson, S. R. Roberts, G. W. Wertz, R. A. Parker, and B. S. Graham. 1998. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge. J. Virol. 72: 2871-2880.
10. Johnson, T. R., M. N. Teng, P. L. Collins, and B. S. Graham. 2004. Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV. J. Virol. 78: 6024-6032. (Pubitemid 38661690)
11. + T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV. J. Virol. 78: 8753-8760.
12. Openshaw, P. J., S. L. Clarke, and F. M. Record. 1992. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int. Immunol. 4: 493-500.
13. Waris, M. E., C. Tsou, D. D. Erdman, S. R. Zaki, and L. J. Anderson. 1996. Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J. Virol. 70: 2852-2860.
14. + T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J. Exp. Med. 186: 421-432.
15. + T cells during experimental virus infection. J. Immunol. 167: 4254-4260.
16. + T-lymphocyte immunodominance in respiratory syncytial virus infection. J. Virol. 81: 2349-2358.
17. Openshaw, P. J., R. M. Pemberton, L. A. Ball, G. W. Wertz, and B. A. Askonas. 1988. Helper T cell recognition of respiratory syncytial virus in mice. J. Gen. Virol. 69(Pt. 2): 305-312. (Pubitemid 18064162)
18. Pemberton, R. M., M. J. Cannon, P. J. Openshaw, L. A. Ball, G. W. Wertz, and B. A. Askonas. 1987. Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen. J. Gen. Virol. 68(Pt. 8): 2177-2182.
19. Castilow, E. M., M. R. Olson, D. K. Meyerholz, and S. M. Varga. 2008. Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus. J. Virol. 82: 2196-2207.
20. + T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 27: 3341-3349.
21. Peebles, R. S., Jr., J. R. Sheller, R. D. Collins, K. Jarzecka, D. B. Mitchell, and B. S. Graham. 2000. Respiratory syncytial virus (RSV)-induced airway hyper-responsiveness in allergically sensitized mice is inhibited by live RSV and exacerbated by formalin-inactivated RSV. J. Infect. Dis. 182: 671-677.
22. + T cells. Immunity 15: 637-646.
23. Matthews, S. P., J. S. Tregoning, A. J. Coyle, T. Hussell, and P. J. Openshaw. 2005. Role of CCL11 in eosinophilic lung disease during respiratory syncytial virus infection. J. Virol. 79: 2050-2057. (Pubitemid 40204562)
24. Castilow, E. M., D. K. Meyerholz, and S. M. Varga. 2008. IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease. J. Immunol. 180: 2376-2384.
25. Monick, M. M., L. S. Powers, I. Hassan, D. Groskreutz, T. O. Yarovinsky, C. W. Barrett, E. M. Castilow, D. Tifrea, S. M. Varga, and G. W. Hunninghake. 2007. Respiratory syncytial virus synergizes with Th2 cytokines to induce optimal levels of TARC/CCL17. J. Immunol. 179: 1648-1658.
26. Culley, F. J., A. M. Pennycook, J. S. Tregoning, T. Hussell, and P. J. Openshaw. 2006. Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology. J. Virol. 80: 4521-4527.
27. 2-microglobulin-deficient mice. Science 255: 1576-1578.
28. + T cells. Int. Immunol. 5: 1193-1198.
29. Walzl, G., S. Matthews, S. Kendall, J. C. Gutierrez-Ramos, A. J. Coyle, P. J. Openshaw, and T. Hussell. 2001. Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology. J. Exp. Med. 193: 785-792. (Pubitemid 32524528)
30. Lukacs, N. W., S. H. Oliveira, and C. M. Hogaboam. 1999. Chemokines and asthma: redundancy of function or a coordinated effort? J. Clin. Invest. 104: 995-999.
31. Sallusto, F., A. Lanzavecchia, and C. R. Mackay. 1998. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today 19: 568-574. (Pubitemid 28557120)
32. Lloyd, C. M., T. Delaney, T. Nguyen, J. Tian, A. C. Martinez, A. J. Coyle, and J. C. Gutierrez-Ramos. 2000. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J. Exp. Med. 191: 265-274.
33. Liu, L. Y., N. N. Jarjour, W. W. Busse, and E. A. Kelly. 2003. Chemokine receptor expression on human eosinophils from peripheral blood and bronchoal-veolar lavage fluid after segmental antigen challenge. J. Allergy Clin. Immunol. 112: 556-562.
34. Rothenberg, M. E., J. A. MacLean, E. Pearlman, A. D. Luster, and P. Leder. 1997. Targeted disruption of the chemokine eotaxin partially reduces antigeninduced tissue eosinophilia. J. Exp. Med. 185: 785-790.
35. Yang, Y., J. Loy, R. P. Ryseck, D. Carrasco, and R. Bravo. 1998. Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine eotaxin. Blood 92: 3912-3923. (Pubitemid 28525218)
36. Gonzalo, J. A., Y. Pan, C. M. Lloyd, G. Q. Jia, G. Yu, B. Dussault, C. A. Powers, A. E. Proudfoot, A. J. Coyle, D. Gearing, and J. C. Gutierrez-Ramos. 1999. Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J. Immunol. 163: 403-411.
37. Kawasaki, S., H. Takizawa, H. Yoneyama, T. Nakayama, R. Fujisawa, M. Izumizaki, T. Imai, O. Yoshie, I. Homma, K. Yamamoto, and K. Matsushima. 2001. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J. Immunol. 166: 2055-2062.
38. Iwamoto, I., H. Nakajima, H. Endo, and S. Yoshida. 1993. Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells. J. Exp. Med. 177: 573-576. (Pubitemid 23117112)
39. Cohn, L., R. J. Homer, N. Niu, and K. Bottomly. 1999. T helper 1 cells and interferon γ regulate allergic airway inflammation and mucus production. J. Exp. Med. 190: 1309-1318. (Pubitemid 29522214)
40. Suzuki, M., K. Maghni, S. Molet, A. Shimbara, Q. A. Hamid, and J. G. Martin. 2002. IFN-gamma secretion by CD8 T cells inhibits allergen-induced airway eosinophilia but not late airway responses. J. Allergy Clin. Immunol. 109: 803-809.
41. Su, S. B., R. S. Grajewski, D. Luger, R. K. Agarwal, P. B. Silver, J. Tang, J. Tuo, C. C. Chan, and R. R. Caspi. 2007. Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-γ deficiency. Invest. Ophthalmol. Vis. Sci. 48: 4616-4625.
42. Hino, R., T. Shimauchi, and Y. Tokura. 2005. Treatment with IFN-γ increases serum levels of Th1 chemokines and decreases those of Th2 chemokines in patients with mycosis fungoides. J. Dermatol. Sci. 38: 189-195. (Pubitemid 40779572)
43. Jakubzick, C., H. Wen, A. Matsukawa, M. Keller, S. L. Kunkel, and C. M. Hogaboam. 2004. Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice. Am. J. Pathol. 165: 1211-1221. (Pubitemid 39297727)
44. Zhang, Y., B. A. Luxon, A. Casola, R. P. Garofalo, M. Jamaluddin, and A. R. Brasier. 2001. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J. Virol. 75: 9044-9058. (Pubitemid 32851909)